FDA Lifts Hold on Cell Therapeutics’ AML Drug

Drug Industry Daily
A A
The FDA has lifted a partial clinical hold on Cell Therapeutics’ blood cancer drug tosedostat, giving the green light for continuing mid-stage clinical trials.

To View This Article:

Login

Subscribe To Drug Industry Daily